Painkiller Maker Settles With FDA Over Moldy Meds

Law360, New York (June 28, 2013, 3:36 PM EDT) -- A New Jersey pain medicine manufacturer that was temporarily shut down after authorities discovered mold in its injectable drug products agreed Thursday to cease operations until it fulfills a raft of compliance obligations mandated by the U.S. Food and Drug Administration.

Med Prep Consulting Inc. signed on to a consent decree in the FDA's lawsuit over the company's allegedly unsanitary drug products. The company has agreed to hire outside consultants to inspect its manufacturing facilities and laboratories and to establish protocols for abiding by so-called current...
To view the full article, register now.